Adjusting Dosing to Increase Efficacy of Cetuximab in Head and Neck Cancer

April 10, 2017
Joseph Ciccolini, PhD

Joseph Ciccolini, PhD, assistant professor in Pharmocokinetics, Aix-Marseille University, discusses how dosing adjustments may be used to increase the efficacy of agents, such as cetuximab (Erbitux) in patients with head and neck cancer.